Literature DB >> 35913505

Isoflavone and soy food intake and risk of lung cancer in never smokers: report from prospective studies in Japan and China.

Choy-Lye Chei1, Norie Sawada2, Nikhil K Khankari3, Motoki Iwasaki1, Taiki Yamaji1, Hui Cai4, Taichi Shimazu1, Manami Inoue1, Xiao-Ou Shu4, Wei Zheng4, Shoichiro Tsugane1.   

Abstract

PURPOSE: Evidence from several cohorts has suggested that a higher intake of isoflavone is associated with lower risk of lung cancer in never smokers, but the association has not been investigated by histologic type of lung cancer. Adenocarcinoma is a common histologic type found in never smokers. We hypothesized that a higher intake of isoflavone is associated with a lower risk of lung adenocarcinoma among never smokers. Here, we examined the associations of isoflavone and soy food intake with lung cancer and its histologic types in never smokers.
METHODS: We performed a pooled analysis using data from the Japan Public Health Center-based Prospective Study, Shanghai Women's Health Study and Shanghai Men's Study with 147,296 never smokers aged 40-74 years with no history of cancer. During 1,990,040 person-years of follow-up, 1247 lung cancer cases were documented. Dietary isoflavone and soy food intake were assessed using a food-frequency questionnaire. Multivariable Cox proportional hazards models assessed the associations between isoflavone and soy intake with incidence of lung cancer by histologic type.
RESULTS: A higher intake of dietary isoflavone and soy food were associated with reduced risk of lung adenocarcinoma. The multivariable hazard ratios (HRs) (95% CI) of risk of lung adenocarcinoma for the highest versus lowest intakes of isoflavone and soy food were 0.74 (0.60-0.92) and 0.78 (0.63-0.96), respectively. The multivariable HRs of risk of lung adenocarcinoma associated with each 10 mg/day increase in isoflavone and each 50 g/day increase in soy food intake were 0.81 (0.70-0.94) and 0.84 (0.73-0.96), respectively.
CONCLUSION: Higher intake of isoflavone and soy food was associated with lower risk of lung adenocarcinoma in never smokers.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cohort; Histologic; Isoflavone; Lung adenocarcinoma; Never smoker; Soy food

Year:  2022        PMID: 35913505     DOI: 10.1007/s00394-022-02968-y

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  40 in total

Review 1.  Lung cancer in never smokers--a review.

Authors:  Sébastien Couraud; Gérard Zalcman; Bernard Milleron; Franck Morin; Pierre-Jean Souquet
Journal:  Eur J Cancer       Date:  2012-03-28       Impact factor: 9.162

2.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

Review 3.  Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens.

Authors:  Isao Okazaki; Shigemi Ishikawa; Wataru Ando; Yasunori Sohara
Journal:  Anticancer Res       Date:  2016-12       Impact factor: 2.480

4.  Lung cancer in never-smokers - what are the differences?

Authors:  Margarida Dias; Rita Linhas; Sérgio Campainha; Sara Conde; Ana Barroso
Journal:  Acta Oncol       Date:  2017-02-17       Impact factor: 4.089

5.  Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice.

Authors:  Daniela Gallo; Gian Franco Zannoni; Ilaria De Stefano; Marco Mosca; Cristiano Ferlini; Elisabetta Mantuano; Giovanni Scambia
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

6.  Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line.

Authors:  F Lian; M Bhuiyan; Y W Li; N Wall; M Kraut; F H Sarkar
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

Review 7.  Lung cancer in never smokers: molecular profiles and therapeutic implications.

Authors:  Charles M Rudin; Erika Avila-Tang; Curtis C Harris; James G Herman; Fred R Hirsch; William Pao; Ann G Schwartz; Kirsi H Vahakangas; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 8.  Lung cancer in never smokers--a different disease.

Authors:  Sophie Sun; Joan H Schiller; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Trends in lung cancer incidence by histological type in Osaka, Japan.

Authors:  Yasuhiro Toyoda; Tomio Nakayama; Akiko Ioka; Hideaki Tsukuma
Journal:  Jpn J Clin Oncol       Date:  2008-08-09       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.